Search for other papers by Felix Reschke in
Google Scholar
PubMed
Search for other papers by Torben Biester in
Google Scholar
PubMed
Search for other papers by Thekla von dem Berge in
Google Scholar
PubMed
Search for other papers by Dagmar Jamiolkowski in
Google Scholar
PubMed
Search for other papers by Laura Hasse in
Google Scholar
PubMed
Search for other papers by Francesca Dassie in
Google Scholar
PubMed
Search for other papers by Pietro Maffei in
Google Scholar
PubMed
Search for other papers by Katharina Klee in
Google Scholar
PubMed
Search for other papers by Olga Kordonouri in
Google Scholar
PubMed
Search for other papers by Hagen Ott in
Google Scholar
PubMed
Search for other papers by Thomas Danne in
Google Scholar
PubMed
11) Chromosome 2 p25 N/a MODY 8: chromosome 9 q34 CEL (carboxyl ester lipase) Chromosome 9 q34 N/a MODY 9 PAX4 (paired box gene 4) Chromosome 7 q32 N/a MODY 10 INS (insulin gene) Chromosome 11 p15.5 N
Search for other papers by Sara Ahmadi in
Google Scholar
PubMed
Search for other papers by Iñigo Landa in
Google Scholar
PubMed
non-LNM vs LNM patients, in the BRAF -positive group. The risk of mortality from cancer in this study was significantly higher in patients with LNM and BRAF V600E (2.9% in patients only with LNM, 1.2% in patients with only BRAF vs 7.8% in patients
Search for other papers by Athanasios Zervas in
Google Scholar
PubMed
National and Kapodistrian University of Athens Medical School, ‘Aghia Sophia’ Children’s Hospital, Athens, Greece
Search for other papers by George Chrousos in
Google Scholar
PubMed
Search for other papers by Sarantis Livadas in
Google Scholar
PubMed
height for chronological age. Hence, if our hypothesis is correct, the dwarfs’ height will certainly have been collectively below the fourth centile on the CDC growth chart ( 7 ). According to the current UK guidelines, this is a height compatible with
Search for other papers by Kjell Oberg in
Google Scholar
PubMed
Search for other papers by Eric Krenning in
Google Scholar
PubMed
Search for other papers by Anders Sundin in
Google Scholar
PubMed
Search for other papers by Lisa Bodei in
Google Scholar
PubMed
Search for other papers by Mark Kidd in
Google Scholar
PubMed
Search for other papers by Margot Tesselaar in
Google Scholar
PubMed
Search for other papers by Valentina Ambrosini in
Google Scholar
PubMed
Search for other papers by Richard P Baum in
Google Scholar
PubMed
Search for other papers by Matthew Kulke in
Google Scholar
PubMed
Search for other papers by Marianne Pavel in
Google Scholar
PubMed
Search for other papers by Jaroslaw Cwikla in
Google Scholar
PubMed
Search for other papers by Ignat Drozdov in
Google Scholar
PubMed
Search for other papers by Massimo Falconi in
Google Scholar
PubMed
Search for other papers by Nicola Fazio in
Google Scholar
PubMed
Search for other papers by Andrea Frilling in
Google Scholar
PubMed
Search for other papers by Robert Jensen in
Google Scholar
PubMed
Search for other papers by Klaus Koopmans in
Google Scholar
PubMed
Search for other papers by Tiny Korse in
Google Scholar
PubMed
Search for other papers by Dik Kwekkeboom in
Google Scholar
PubMed
Search for other papers by Helmut Maecke in
Google Scholar
PubMed
Search for other papers by Giovanni Paganelli in
Google Scholar
PubMed
Search for other papers by Ramon Salazar in
Google Scholar
PubMed
Search for other papers by Stefano Severi in
Google Scholar
PubMed
Search for other papers by Jonathan Strosberg in
Google Scholar
PubMed
Search for other papers by Vikas Prasad in
Google Scholar
PubMed
Search for other papers by Aldo Scarpa in
Google Scholar
PubMed
Search for other papers by Ashley Grossman in
Google Scholar
PubMed
Search for other papers by Annemeik Walenkamp in
Google Scholar
PubMed
Search for other papers by Mauro Cives in
Google Scholar
PubMed
Search for other papers by Irene Virgolini in
Google Scholar
PubMed
Search for other papers by Andreas Kjaer in
Google Scholar
PubMed
Search for other papers by Irvin M Modlin in
Google Scholar
PubMed
tumor biology, disease extent at diagnosis, available therapeutic options and designated centers of care ( 7 , 8 , 9 ). Therapeutic options remain diverse and run the full gamut from mechanistic excision to pharmacological intervention and the infusion
Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
). TSH The expression of TSH receptor (TSHR) was firstly reported in osteoblasts by Inoue et al. in 1998 ( 6 ) and in osteoclasts by Abe et al. in 2005 ( 7 ). No data is available on osteocytes. In vitro experiments have shown contradictory
Search for other papers by Alice Costantini in
Google Scholar
PubMed
Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland
Search for other papers by Mari H Muurinen in
Google Scholar
PubMed
Folkhälsan Institute of Genetics, University of Helsinki, Helsinki, Finland
Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland
Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Outi Mäkitie in
Google Scholar
PubMed
zones, each of which is composed of chondrocytes characterized by different size, shape, orientation, proliferative capacity, and function: (1) resting zone, (2) proliferative zone and (3) hypertrophic zone ( 7 ). The resting zone is a source of stem